伊伐布雷定对癌症治疗相关心脏功能障碍所致失代偿性心力衰竭的影响。
Impact of ivabradine in decompensated heart failure due to cancer therapy-related cardiac dysfunction.
作者信息
Nakano Yusuke, Ando Hirohiko, Suzuki Wataru, Ohashi Hirofumi, Suzuki Yasushi, Takashima Hiroaki, Amano Tetsuya
机构信息
Department of Cardiology Aichi Medical University Nagakute Japan.
出版信息
Clin Case Rep. 2021 May 5;9(5):e04133. doi: 10.1002/ccr3.4133. eCollection 2021 May.
Abstract
In cases of decompensated heart failure related to cancer therapy-related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorable hemodynamics. Assessment of the overlap between the E- and A-waves facilitates understanding the effects of ivabradine in such cases.
摘要
在与癌症治疗相关的心脏功能障碍所致失代偿性心力衰竭病例中，使用伊伐布雷定可通过降低窦性心率来增加每搏输出量，从而产生有利的血流动力学效果。评估E波和A波之间的重叠情况有助于了解伊伐布雷定在此类病例中的作用。
Zotero 插件